---
title: "Celularity appoints Steven N. Gordon as COO and K. Harold Fletcher as CLO & Corporate Secretary"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/290882915.md"
description: "Celularity Inc. has appointed Steven N. Gordon as Chief Operating and Administrative Officer and K. Harold Fletcher as Chief Legal and Strategy Officer and Corporate Secretary, effective June 19, 2026. Gordon, also elected to the Board, brings experience in corporate finance and operations. Fletcher, with a background in securities law and healthcare compliance, previously served as General Counsel. These appointments aim to strengthen the company's operational and legal leadership."
datetime: "2026-06-25T21:33:00.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/290882915.md)
  - [en](https://longbridge.com/en/news/290882915.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/290882915.md)
generator: "portal-rs"
---

# Celularity appoints Steven N. Gordon as COO and K. Harold Fletcher as CLO & Corporate Secretary

**Celularity appointed Steven N. Gordon as Chief Operating and Administrative Officer and K. Harold Fletcher as Chief Legal and Strategy Officer and Corporate Secretary, both effective June 19, 2026.**

**Individual**

Steven N. Gordon, Esq.

K. Harold Fletcher, Esq.

**Role**

Chief Operating and Administrative Officer; Director

Chief Legal and Strategy Officer; Corporate Secretary

**Type of Change**

Appointed (also elected to Board)

Appointed

**Effective Date**

June 19, 2026

June 19, 2026

**Reason**

Board appointment to lead operations and administrative functions

Board appointment to lead legal and strategy functions

**Replacement Info**

Not disclosed

Not disclosed

**Background Details**

Entrepreneur, investor and exec with experience in corporate finance, operations, strategic development and capital formation; served as EVP, Business Affairs since Jan 2026

Experience in corporate governance, securities law, strategic transactions, financings, healthcare compliance and public company matters; served as EVP, Legal and Strategy since Jan 2026 and previously as General Counsel, Chief Compliance Officer and Assistant Corporate Secretary

**Board/Committee Role Changes**

Appointed to Board; will serve until successor elected or earlier resignation, death or removal

Not disclosed

Original SEC Filing: Celularity Inc \[ CELU \] - 8-K - Jun. 25, 2026

**Disclaimer**

This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.

### Related Stocks

- [CELU.US](https://longbridge.com/en/quote/CELU.US.md)
- [CELUW.US](https://longbridge.com/en/quote/CELUW.US.md)

## Related News & Research

- [Nexgel’s Celularity Deal: Execution, Integration, and Profitability Risks from $13.3 Million Biomaterials Acquisition](https://longbridge.com/en/news/296183101.md)
- [11:19 ETEon Appoints Matthew Lungren, MD, MPH, to Board of Directors](https://longbridge.com/en/news/296375443.md)
- [National Healthcare Properties director Albert M. Campbell III files initial beneficial ownership statement](https://longbridge.com/en/news/296401234.md)
- [Nordson publishes investor presentation outlining third-quarter 2026 results and growth strategy](https://longbridge.com/en/news/296480398.md)
- [Fletcher Building publishes FY2026 annual report](https://longbridge.com/en/news/296269712.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**